Meiying H. Zhang
#28 Fuxing Road
Beijing, 100853, China
Beijing, 100853, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitor.
Journal: Cancer biology & therapy
Published: March 25, 2026
L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer.
Journal: Exploration of targeted anti-tumor therapy
Published: December 24, 2025
Lnc5q21.2, a novel long intergenic RNA, sensitizes colorectal cancer cells to ATR inhibitor by activating Wnt pathway.
Journal: Journal of translational internal medicine
Published: October 31, 2025
Defect of MLH1 expression sensitized esophageal squamous cell carcinoma cells to Polθ inhibitor.
Journal: Epigenomics
Published: October 30, 2025
A novel lncRNA, Lnc21q22.11, suppresses gastric cancer growth by inhibiting MEK/ERK pathway.
Journal: Epigenetics
Published: June 02, 2025
Corrigendum: Attitudes toward palliative care among cancer patients: a multi-method study.
Journal: Frontiers in public health
Published: March 24, 2025
A novel mechanism by which c-MYC is aberrantly activated by epigenetic silencing of its antisense lncRNA in colon cancer.
Journal: Frontiers in genetics
Published: December 27, 2024
Impact of ketogenic diets on cancer patient outcomes: a systematic review and meta-analysis.
Journal: Frontiers in nutrition
Published: November 28, 2024
Attitudes toward palliative care among cancer patients: a multi-method study.
Journal: Frontiers in public health
Published: October 15, 2024
Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer.
Journal: Journal of translational internal medicine
Published: July 31, 2024
Palliative care screening tools and patient outcomes: a systematic review.
Journal: BMJ supportive & palliative care
Published: July 19, 2024
Last Updated: 09/26/2026